Ngari virus
Ngari virus is a virus that belongs to the family Bunyaviridae, specifically the genus Orthobunyavirus. It is known to cause severe illness in humans, including hemorrhagic fever and encephalitis. The virus was first identified in 1996 in the Ngari region of Sudan, from which it derives its name.
History[edit]
The Ngari virus was first isolated in 1996 during an outbreak of febrile illness in the Ngari region of Sudan. The virus was identified through serological testing, which revealed it to be a novel member of the Orthobunyavirus genus.
Transmission[edit]
Ngari virus is primarily transmitted to humans through the bite of infected mosquitoes. The virus has been detected in several species of mosquitoes, including Aedes and Culex species. It is believed that the virus is maintained in nature through a cycle involving mosquitoes and mammalian hosts.
Clinical Manifestations[edit]
Infection with Ngari virus can result in a range of clinical manifestations, from mild febrile illness to severe disease. Symptoms may include fever, headache, muscle pain, joint pain, and fatigue. In severe cases, the virus can cause hemorrhagic fever and encephalitis, which can be fatal.
Diagnosis[edit]
Diagnosis of Ngari virus infection is typically made through serological testing. Polymerase chain reaction (PCR) testing can also be used to detect the virus in blood samples.
Treatment and Prevention[edit]
There is currently no specific treatment for Ngari virus infection. Management of the disease is primarily supportive, including rehydration and treatment of symptoms. Prevention strategies focus on reducing exposure to mosquitoes, including the use of insect repellent and mosquito nets.
Research[edit]
Research into Ngari virus is ongoing, with efforts focused on understanding the virus's epidemiology, pathogenesis, and potential treatment options.
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian